• FLCN mRNA Rescue: What the BHD Study Shows

  2026-10-12

  A 2026 study links two FLCN variants to Birt-Hogg-Dubé syndrome and reports mRNA-mediated rescue of FLCN expression and mTORC1 signaling in cultured HEK293T cells. The findings support a mechanistic proof of concept, not a validated treatment.

• MOG (35-55) in EAE and Neuroinflammation Research

  2026-10-10

  A source-grounded overview of MOG (35-55) as an experimental autoimmune encephalomyelitis research tool, with emphasis on model context, conceptual applications, PARP7–interferon findings, evidence strength, and translational limitations.

• EGTA and the Translational Logic of Calcium Signaling

  2026-10-09

  EGTA, also known as egtazic acid, can help translational researchers test whether extracellular calcium is causal in endothelial inflammation, neuroprotection, and apoptosis-related phenotypes. This thought-leadership perspective connects the compound to the Talin1–Piezo1–YAP axis while defining the evidence limits that separate a useful mechanistic probe from a therapeutic claim.

• 7-Ethyl-10-hydroxycamptothecin: SN-38 Evidence

  2026-10-09

  7-Ethyl-10-hydroxycamptothecin, also known as SN-38, is best understood through two connected but distinct mechanisms: topoisomerase I poisoning and interference with FUBP1–FUSE binding. This evidence-focused review separates established findings from hypotheses relevant to advanced colon cancer research.

• Gene-Modulating Therapies for ATTR-CM

  2026-10-08

  Ang, Chia, and Mukherjee’s 2025 mini-review examines how siRNA, antisense oligonucleotides, and CRISPR-Cas9 are shifting transthyretin amyloid cardiomyopathy research from protein stabilization toward suppression of the disease-causing protein at its source. The review highlights substantial reductions in transthyretin and encouraging biomarker findings, while emphasizing that durability, long-term safety, and comparative effectiveness remain unresolved.

• Artesunate Beyond IC50: Reading Cancer Cell Death

  2026-10-08

  Artesunate responses cannot be interpreted from IC50 alone. This article applies Schwartz’s growth-versus-death framework to ferroptosis, AKT/mTOR signaling, and model-specific evidence in cancer research.

• Artesunate: From Viability to Cell Death

  2026-10-07

  Artesunate research is more informative when growth inhibition is separated from true cell killing. This evidence-focused analysis connects the B3662 compound profile with a dissertation-based framework for interpreting ferroptosis, pyroptosis, and AKT/mTOR-related findings.

• BIIE 0246: Y2R Antagonist Evidence

  2026-10-07

  BIIE 0246 is a neuropeptide Y Y2 receptor antagonist used to study Y2R-mediated signaling in neural, feeding, and behavioral models. Its reported nanomolar binding metrics support receptor-focused research, while the adipose-neural arrhythmia study identifies Y1R—not Y2R—as the NPY receptor linked to the reported cardiac mechanism.

• Palbociclib: From CDK4/6 Arrest to Cancer Biology

  2026-10-06

  Palbociclib and PD0332991 are examined through the CDK4/6–Rb axis, with emphasis on how cell-cycle arrest can complicate interpretation of apoptosis and DNA-damage studies. The article connects product evidence with the ERCC1–p53 findings of Heyza et al. while defining translational limits.

• Amitriptyline HCl Product Overview

  2026-10-06

  Amitriptyline HCl (SKU B2231) is a supplier-listed tricyclic small molecule for conceptual neuropharmacology research involving neurotransmitter receptor modulation. No matched paper evidence was provided, so performance, mechanism, and application-specific conclusions cannot be established here.

• Diethylmaleate: Interpreting Redox Evidence

  2026-10-05

  Diethylmaleate is more than a GSH-depletion chemical: it is a valuable lens for separating GST activity, antioxidant defense, and oxidative-stress phenotypes. This article interprets recent insect toxicology evidence while defining the compound’s broader research value and limitations.

• Artesunate: From Mechanism to Translational Signal

  2026-10-05

  Artesunate is best viewed not as a single-endpoint cytotoxicity tool, but as a mechanistically interesting artemisinin derivative whose translational value depends on separating growth suppression from actual cell killing. This article connects ferroptosis, pyroptosis, AKT/mTOR biology, model selection, and time-aware response interpretation while defining the evidence limits around current claims.

• UV-Fenton Degradation of Sulfisomidine: What the Study Shows

  2026-10-04

  Hong et al. examined how UV-Fenton treatment affects sulfisomidine and three other refractory pharmaceuticals in both ultrapure water and a complex landfill-derived water matrix. The study’s main contribution was to connect degradation kinetics with transformation-product identification, QSAR toxicity prediction, and HepG2-cell responses, showing that parent-compound removal does not necessarily mean immediate toxicity reduction.

• Potato Virus X Nanoparticles for RNA Delivery

  2026-10-03

  Duoto and colleagues develop potato virus X coat-protein assemblies as a flexible platform for packaging custom mRNA and circular RNA. Their findings show that filamentous, halo-shaped, compositionally mixed, and length-tunable particles can support reporter delivery and protein expression, while also highlighting the gap between proof-of-concept transfection and therapeutic validation.

• TUNEL Apoptosis Detection Kit for SCI Research

  2026-10-02

  Translate spinal cord injury biology into a practical DNA-fragmentation workflow for both tissue sections and cultured endothelial cells. The DAB-based readout combines spatial context, standard light microscopy, and defined controls for research teams studying quercetin-associated vascular protection and apoptosis.

8635 records 1/576 page Next 12345 下5页 Last page